COVID-19 update – Our clinics are open and we’re taking bookings Read more

We are now taking bookings for our Harley Street clinic. You can use our online booking system or phone 0800 030 6617 to talk to an administrator.

Our other clinics around the country are open, so please contact us to find out when the earliest appointment at your preferred clinic will be.

During appointments, our clinicians and audiologists are working in a safe manner to reduce infection and help you recover from your tinnitus. We clean surfaces between patient appointments in line with Government guidance and that issued by the British Society of Audiology.

We will require you to answer a few questions before you come into clinic to minimise the risk of spreading COVID-19 infection.

Remember, if you're unable to attend a clinic we run a full telecare service with remote assessments and fittings using video through our e‑consult service.

X close COVID-19 update


Acoustic CR® Neuromodulation paper published in Frontiers in Neurology

  March 16, 2015




A new patient study on Acoustic CR® Neuromodulation, conducted by our Chief Audiologist Mark Williams and colleagues from the UK and Germany, has been published in the international peer reviewed journal, Frontiers in Neurology.

The paper, entitled Acoustic CR® Neuromodulation therapy for subjective tonal tinnitus: a review of clinical outcomes in an independent audiology practice setting, was authored by Mark Williams and Nitesh Patel of The Tinnitus Clinic and Christian Hauptmann of the Julich Research Center, Germany. Mark also provided an academic poster presentation of this study, at the end of last year, for the British Academy of Audiology Conference in Bournemouth.

The study focused on 66 patients, aged between 31 and 76 years, who were receiving Acoustic CR® Neuromodulation therapy for the treatment of tinnitus. The majority of patients taking part in this study had already undergone unsuccessful structured tinnitus therapy elsewhere. 50% of the patients had severe or catastrophic levels of tinnitus.

The clinicians found that, two-thirds of the way through the treatment programme (at 22-26 weeks), the majority of the patients were already experiencing significant reductions in the loudness/annoyance of the tinnitus symptoms and improvements in their quality of life. These changes are detailed below.

73%

of patients experienced a clinically significant reduction of annoyance1 after 22-26 weeks using Acoustic CR® Neuromodulation

60%

of patients experienced a clinically significant reduction of loudness2 after 22-26 weeks using Acoustic CR® Neuromodulation

60%

of patients experienced a clinically significant improvement in the physical, emotional and social consequences of tinnitus (THQ scores3) after 22-26 weeks using Acoustic CR® Neuromodulation


Studies in Germany and in-clinic experience at The Tinnitus Clinic in the UK have also revealed further and sustainable improvements in tinnitus annoyance and loudness after 26 weeks.

If you are interested in finding out more about this innovative treatment for tinnitus, see the Acoustic CR® Neuromodulation section of our website, or call the Clinic on 0203 597 4988.


1 + 2. The degree of discomfort caused by tinnitus was evaluated using an internationally recognised (Visual Analogue Scale - VAS) method of determining the loudness of a patient's tinnitus and the level of annoyance that it causes.
3. Another measure of the effect of tinnitus is the Tinnitus Handicap Questionnaire (THQ) which serves to assess the social, emotional and behavioral consequences of experiencing tinnitus and how this state may change over time.




  Back to Tinnitus News





Blue Calendar Icon

Book an Appointment


  Book Now

Our Clinics

The Tinnitus Clinic has clinics throughout the UK